FGADX
Price
$50.30
Change
-$0.71 (-1.39%)
Updated
Jun 22 closing price
Net Assets
3.12B
RYMNX
Price
$246.79
Change
-$4.64 (-1.85%)
Updated
Jun 22 closing price
Net Assets
150.03M
Interact to see
Advertisement

FGADX vs RYMNX

FGADX vs RYMNX Comparison Chart in %
View a ticker or compare two or three
VS
FGADX vs. RYMNX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGADX is a Buy and RYMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGADX has more cash in the bank: 3.13B vs. RYMNX (150M). FGADX pays higher dividends than RYMNX: FGADX (9.06) vs RYMNX (3.01). FGADX was incepted earlier than RYMNX: FGADX (29 years) vs RYMNX (22 years). RYMNX (1.59) is less costly to investors than FGADX (0.62). RYMNX is a more actively managed with annual turnover of: 452.00 vs. FGADX (22.76). FGADX has a lower initial minimum investment than RYMNX: FGADX (0) vs RYMNX (2500). FGADX annual gain was more profitable for investors over the last year : 79.15 vs. RYMNX (67.37). FGADX return over 5 years is better than : 174.45 vs. RYMNX (108.02).
FGADXRYMNXFGADX / RYMNX
Total Expense Ratio0.621.5440%
Annual Report Gross Expense Ratio0.621.5939%
Fund Existence29 years22 years-
Gain YTD-0.3520.155-226%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.13B150M2,083%
Annual Yield % from dividends9.063.01301%
Returns for 1 year79.1567.37117%
Returns for 3 years261.53180.49145%
Returns for 5 years174.45108.02161%
Returns for 10 years284.80171.92166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI23.750.37
+1.58%
Greenwich LifeSciences
STBA47.310.47
+1.00%
S&T Bancorp
MGLD1.060.01
+0.95%
Marygold Companies (The)
HALO68.980.43
+0.63%
Halozyme Therapeutics
WENNU10.41N/A
N/A
Wen Acqusition Corp